• Lung cancer therapy including novel compounds and early phase trials
  • Breast cancer therapeutics including novel compounds and early phase trials
  • Health services research
  • Economics of lung cancer therapy
  • Treatment decision-making in advanced cancer, including development of patient decision aids
  • Patient-physician communication
Curr Oncol. 2019 Feb;26(1):e81-e93
Laurie SA, Banerji S, Blais N, Brule S, Cheema PK, Cheung P, Daaboul N, Hao D, Hirsh V, Juergens R, Laskin J, Leighl N, MacRae R, Nicholas G, Roberge D, Rothenstein J, Stewart DJ, Tsao MS
Clin Lung Cancer. 2018 Dec 22;:
Ezeife DA, Morganstein BJ, Lau S, Law JH, Le LW, Bredle J, Cella D, Doherty MK, Bradbury P, Liu G, Sacher A, Shepherd FA, Leighl NB
Clin Lung Cancer. 2018 Dec 19;:
Tomasini P, Mascaux C, Jao K, Labbe C, Kamel-Reid S, Stockley T, Hwang DM, Leighl NB, Liu G, Bradbury PA, Pintilie M, Tsao MS, Shepherd FA
Cancer. 2019 Feb 15;:
Kanjanapan Y, Day D, Wang L, Al-Sawaihey H, Abbas E, Namini A, Siu LL, Hansen A, Razak AA, Spreafico A, Leighl N, Joshua AM, Butler MO, Hogg D, Chappell MA, Soultani L, Chow K, Boujos S, Bedard PL
Eur J Cancer. 2019 Jan 24;109:28-35
Lai WV, Lebas L, Barnes TA, Milia J, Ni A, Gautschi O, Peters S, Ferrara R, Plodkowski AJ, Kavanagh J, Sabari JK, Clarke SJ, Pavlakis N, Drilon A, Rudin CM, Arcila ME, Leighl NB, Shepherd FA, Kris MG, Mazières J, Li BT
Eur J Cancer. 2018 Dec 06;107:1-7
Kanjanapan Y, Day D, Butler MO, Wang L, Joshua AM, Hogg D, Leighl NB, Razak ARA, Hansen AR, Boujos S, Chappell M, Chow K, Sherwin B, Stayner LA, Soultani L, Zambrana A, Siu LL, Bedard PL, Spreafico A
Cancer Cytopathol. 2018 Dec 04;:
Young K, da Cunha Santos G, Card P, Leighl N
Oncologist. 2018 Nov 26;:
Soldera SV, Kavanagh J, Pintilie M, Leighl NB, de Perrot M, Cho J, Hope A, Feld R, Bradbury PA
Curr Oncol. 2018 Oct;25(5):e385-e390
Ezeife DA, Melosky B, Tudor R, Lin S, Lau A, Panzarella T, Leighl NB

Pages


Associate Professor, Department of Medicine, University of Toronto
President, Lung Cancer Canada
Chair, Working Group on Economic Analysis, National Cancer Institute of Canada Clinical Trials Group​